Natco Pharma Limited - Company Profile

It is a agriculture public limited company based in Hyderabad, Telangana, India, established in 1981.

1981 Hyderabad, Telangana, India Active

Last Updated: December 22, 2025

About Natco Pharma Limited

Natco Pharma Limited, a active public limited company, was established on 19 September 1981 in Hyderabad, Telangana, India. Engaging in fertilizers & soil enhancers within the manufacturing sector, it holds CIN: L24230TG1981PLC003201. Registered under ROC Roc Hyderabad. it is listed on BSE: 524816 and NSE: NATCOPHARM. It has an authorized capital of ₹45.00 Cr and a paid-up capital of ₹35.82 Cr.

Formerly known as Natco Fine Pharmaceuticals Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹3,673.60 Cr and a net worth of ₹5,592.32 Cr. Employing 4,652 professional, Its leadership includes Lakshminarayana Bolisetty (Director), Rajeev Nannapaneni (Whole-Time Director), Vijayabhaskar Dronadula (Director). Past directors included Sreerama Murthy Gubbala, Bhim Sain Bajaj, Kali Satya Bhujanga Rao Adibhatla. It holds ₹1,120.00 Cr open charges and ₹1,277.71 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Natco House , Road No.2, Banjara Hills, Hyderabad, Telangana, 500034.

Company Details

CIN/LLPIN
L24230TG1981PLC003201
Registration Number
003201
Incorporation Date
19 September 1981
Authorized Capital
₹45.00 Cr
Paid-Up Capital
₹35.82 Cr
ROC Code
Roc Hyderabad
Listing Status
Listed (BSE: 524816, NSE: NATCOPHARM)
Company Status
Active

Key Metrics

Authorised Capital ₹ 45.00 Cr as on 22-12-2025
Paid Up Capital ₹ 35.82 Cr as on 22-12-2025
Company Age 44 Year, 6 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 1,120.00 Cr as on 22-12-2025
Satisfied Charges ₹ 1,277.71 Cr as on 22-12-2025
Revenue Growth **** 50.77% (FY 2024)
Profit Growth **** 105.09% (FY 2024)
Ebitda **** 93.80% (FY 2024)
Net Worth 18.94% (FY 2024)
Total Assets **** 21.64% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Natco Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Natco Pharma Limited?

Current Directors

Name	Designation	Appointment Date	Status
Lakshminarayana Bolisetty	Director	12 Aug 2024	Current
Rajeev Nannapaneni	Whole-Time Director	01 Jun 2012	Current
Vijayabhaskar Dronadula	Director	01 Apr 2024	Current
Nitin Rameshwar Jain	Director	12 Aug 2024	Current
Potluri Prasad Sivaramakrishna	Whole-Time Director	12 Nov 2014	Current
Venkaiah Chowdary Nannapaneni	Managing Director	01 Apr 2015	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	01 Apr 2024	Past
Pramod Abcsdd	Director	07 Aug 2017	Past
Pramod Abcsdd	Whole-Time Director	07 Aug 2017	Past
Pramod Abcsdd	Alternate Director	12 Aug 2015	Past
Pramod Abcsdd	Additional Director	29 Sep 2024	Past
Pramod Abcsdd	Nominee Director	18 Apr 2012	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Natco Pharma.

Natco Pharma Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 50.77% increase. The company also saw a substantial improvement in profitability, with a 105.09% increase in profit. The company's net worth Soared by an impressive increase of 18.94%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

50.77%

*******

Revenue from Operations

*******

51.80%

*******

Total Assets

*******

21.64%

*******

Profit or Loss

*******

105.09%

*******

Net Worth

*******

18.94%

*******

EBITDA

*******

93.80%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Natco Pharma?

In 2024, Natco Pharma had a promoter holding of 49.71% and a public holding of 50.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹11,200,000,000.00

Satisfied Charges

₹12,777,129,822.00

Charges Breakdown by Lending Institutions

State Bank Of India : 600.00 Cr
Others : 520.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
18 Jul 2025	State Bank Of India	₹600.00 Cr	Open
08 Mar 2011	Others	₹520.00 Cr	Open
18 Oct 2016	Others	₹50.00 Cr	Satisfied
22 Jun 2015	Citi Bank N.A.	₹12.05 Cr	Satisfied
22 Dec 2014	Citi Bank N.A.	₹60.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Natco Pharma?

Natco Pharma has a workforce of 4652 employees as of Aug 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Natco Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natco Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Natco Pharma

Recent Activity within the Organization

Charges

Progress on A charge with State Bank Of India amounted to Rs. 600.00 Cr with Charge ID 101136057 was registered on 18 Jul 2025. was documented.
18 Jul 2025
Annual General Meeting

Progress on Natco Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
30 Sep 2024
Director Appointment

Lakshminarayana Bolisetty was appointed as a Director was appointed as a Director on 12 Aug 2024 & has been associated with this company since 1 year 7 months . was recorded as a recent event.
12 Aug 2024
Director Appointment

The activity Nitin Rameshwar Jain was appointed as a Director was appointed as a Director on 12 Aug 2024 & has been associated with this company since 1 year 7 months . was completed.
12 Aug 2024
Director Appointment

Kantipudi Suma was appointed as a Director was appointed as a Director on 12 Aug 2024 & has been associated with this company since 1 year 7 months . was recorded as a recent event.
12 Aug 2024
Director Appointment

Vijayabhaskar Dronadula was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 1 year 11 months . was recorded as a recent event.
01 Apr 2024

Explore recent activity and updates - View Recent Activity